CRISPR/Cas9-mediated generation of hESC lines with homozygote and heterozygote p.R331W mutation in CTBP1 to model HADDTS syndrome

Summary

C-terminal Binding Protein 1 (CTBP1) is a ubiquitously expressed transcriptional co-repressor and membrane trafficking regulator. A recurrent de novo c.991C>T mutation in CTBP1 leads to expression of p.R331W CTBP1 and causes hypotonia, ataxia, developmental delay, and tooth enamel defects syndrome (HADDTS), a rare early onset neurodevelopmental disorder. We generated hESCs lines with heterozygote and homozygote c.991C>T in CTBP1 using CRISPR/Cas9 genome editing and validated them for genetic integrity, off-target mutations, and pluripotency. They will be useful for investigation of HADDTS pathophysiology and for screening for potential therapeutics. Copyright © 2023 The Authors. Published by Elsevier B.V. All rights reserved.

Authors Akdaş EY, Turan S, Guhathakurta D, Ekici A, Salar S, Lie DC, Winner B, Fejtova A
Journal Stem cell research
Publication Date 2023 Mar;67:103012
PubMed 36610307
DOI 10.1016/j.scr.2022.103012

Research Projects

Cell Lines

  • (none)